- Home
- News
Current news from our company
News
New Portfolio Expansion: SERION autoimmune
March highlights Autoimmune Awareness Month — a time to advance awareness, strengthen collaboration, and drive meaningful progress in autoimmune care. We are proud to mark this month with an important milestone: the expansion of our portfolio into recombinant autoimmune antigens.
read morePioneering Compliance with New Industry Standards
Institut Virion\Serion GmbH Achieves IVDR Certification for Class B Products
read moreIVDR certificate class C
The IVDR certificate for our class C products with identifier HX 1098896-1 and effective date 2024-05-16
read moreFight Sepsis!
Virion\Serion receives research funding by the German Federal Ministry of Education and Research (BMBF)
read moreNew Release: SERION easyCSF
Software solution for comprehensive and automated CSF diagnostics
read moreOutstanding study results
Our SERION ELISA agile SARS-CoV-2 IgG was tested in an Independent study against 7 assays from competitors.
read moreNow available: SERION ELISA classic Dengue Virus superior IgM
We are very happy to announce that the new SERION ELISA classic Dengue Virus superior IgM test will supplement our panel for the detection of tropical infectious diseases.
read moreAvailability of SERION products
Concerning the global development of the Coronavirus (SARS-CoV-2), Institut Virion\Serion GmbH still assures the continuous supply of our products to our distributors and customers.
read moreSuccessful trade fair at MEDLAB Middle East in Dubai
Institut Virion\Serion GmbH experienced four successful days in Dubai.
read moreVisit us at the MEDLAB Middle East in Dubai
We look forward to welcoming you at our booth Z6.F48 at MEDLAB.
read more